Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 614-637-2 | CAS number: 68603-75-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1981-06-02 to 1981-08-04
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restrictions ( medullar toxicity is not checked through PCE/NCE ratio but through haematological analysis, 5 animals per sex are usually required (instead of only 4 here))
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- 4 instead of 5 animals per sex
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 1-({3-[(2-hydroxypropyl)[(9E)-octadec-9-en-1-yl]amino]propyl}amino)propan-2-ol; 1-({3-[(2-hydroxypropyl)amino]propyl}(octadecyl)amino)propan-2-ol; 1-({3-[hexadecyl(2-hydroxypropyl)amino]propyl}amino)propan-2-ol
- EC Number:
- 614-637-2
- Cas Number:
- 68603-75-8
- Molecular formula:
- R-N(CH2CHOHCH3)xCH2CH2CH2N(CH2CHOHCH3)y with x+y=3 and where R = alkyl
- IUPAC Name:
- 1-({3-[(2-hydroxypropyl)[(9E)-octadec-9-en-1-yl]amino]propyl}amino)propan-2-ol; 1-({3-[(2-hydroxypropyl)amino]propyl}(octadecyl)amino)propan-2-ol; 1-({3-[hexadecyl(2-hydroxypropyl)amino]propyl}amino)propan-2-ol
- Details on test material:
- - Name of test material (as cited in study report): DINORAM SL
- Physical state: dark brown liquid
- Lot/batch No.: 2884
No other data available
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Source: Charles River France (76410 Saint-Aubin-lès-Elbeuf, France)
- Age: 13-17 weeks
- Body weight at study initiation: no data
Administration / exposure
- Route of administration:
- other: test substance gavage, positive controls intraperitoneal
- Vehicle:
- Vehicle: CMC at 1%
- Duration of treatment / exposure:
- 2 administrations separated by 24h
- Frequency of treatment:
- 2 administrations separated by 24h
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0.1, 0.2 and 0.5 ml/kg
Basis:
- No. of animals per sex per dose:
- 4 males + 4 females
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Benzo(a)pyrene (500 mg/kg/day) and Cyclophosphamide (100 mg/kg/day) in corn oil
Examinations
- Details of tissue and slide preparation:
- - Haematology: blood samples were withdrawn from retro-orbital sinus for measuring red blood count, mean cell volume, hematocrit, hemoglobin, mean cell hemoglobin concentration and white cell count
- Tissue examined: blood and bone marrow - Actual dose (mg/kg body weight): not determined
- Slide preparation: At the scheduled sacrifice times (30 hours after the second administration for test substance and negative control groups, 48h hours after the second administration for positive control groups), mice were sacrificed by vertebras dislocation. Immediately following sacrifice, the femurs were removed and the bone marrow was flushed with fetal calf serum. The bone marrow cells were transferred to labelled centrifuge tubes. The bone marrow cells were pelleted by centrifugation at 1200 g for 5 minutes and the supernatant was drawn off, leaving a small amount of serum with the remaining cell pellet. The cells were resuspended with serum and a small volume of bone marrow suspension was spread onto two clean glass slides. The slides were stained with May-Grünwald-Giemsa.
- PCE/NCE ratio was determined until a total of at least 1000 cells (PCE+NCE) were counted Each slide is examined by two persons.
- A total of 1000 PCE was examined for micronuclei. - Statistics:
- Comparisons between treated and control groups were performed using a Student Fischer test.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- - Mortality: No death occured in test substance group but a male was found dead after the second administration.
- Clinical findings: No pathological effects were reported.
- Haematology: No significant differences in haematological parameters between treated and negative control groups were noted. Notably, no anemia were recorded.
- Micronuclei count: No significant differences were observed between treated and negative control group. In contrast, positive control slides showed an increased micronuclei count.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Under these experimental conditions, the substance did not show a clastogenic potential. - Executive summary:
Four male and four female mice were treated with 0.1, 0.2 or 0.5 mg/kg/d of Amines, N-tallow alkyltrimethylenedi-, propoxylated on two days. Blood of the animals was taken for hematological observations, bone marrow samples were taken for investigation of micronucleus formation. Neither in the blood samples nor in the bone marrow samples, differences between control animals and dosed animals were observed. The animals treated with positive controls (Benzo(a)pyrene and Cyclophosphamide), however did show a markedly increased number in micronuclei.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.